[
    {
        "company": "Agios Pharm",
        "drug": "EZETIMIBE AND SIMVASTATIN",
        "type": "FDA Approval",
        "date": "2024-05-30",
        "title": "EZETIMIBE AND SIMVASTATIN - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A201890",
        "source": "openFDA API"
    },
    {
        "company": "Ionis Pharma",
        "drug": "CARGLUMIC ACID",
        "type": "FDA Approval",
        "date": "2024-05-30",
        "title": "CARGLUMIC ACID - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A213729",
        "source": "openFDA API"
    },
    {
        "company": "Ionis Pharma",
        "drug": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE",
        "type": "FDA Approval",
        "date": "2024-06-24",
        "title": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE - ORIG Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A204135",
        "source": "openFDA API"
    },
    {
        "company": "Bioage Labs",
        "drug": "DABIGATRAN ETEXILATE MESYLATE",
        "type": "FDA Approval",
        "date": "2024-08-16",
        "title": "DABIGATRAN ETEXILATE MESYLATE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A208040",
        "source": "openFDA API"
    },
    {
        "company": "Ionis Pharma",
        "drug": "LITHIUM CARBONATE",
        "type": "FDA Approval",
        "date": "2024-08-19",
        "title": "LITHIUM CARBONATE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A076170",
        "source": "openFDA API"
    },
    {
        "company": "Agios Pharm",
        "drug": "BUPROPION HYDROCHLORIDE",
        "type": "FDA Approval",
        "date": "2024-10-01",
        "title": "BUPROPION HYDROCHLORIDE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A211200",
        "source": "openFDA API"
    },
    {
        "company": "Ionis Pharma",
        "drug": "SOVUNA",
        "type": "FDA Approval",
        "date": "2024-10-10",
        "title": "SOVUNA - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214581",
        "source": "openFDA API"
    },
    {
        "company": "Sarepta",
        "drug": "EXONDYS 51",
        "type": "FDA Approval",
        "date": "2024-12-27",
        "title": "EXONDYS 51 - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206488",
        "source": "openFDA API"
    },
    {
        "company": "Arcturus Therapeutics Holdings Inc",
        "drug": "FRINDOVYX",
        "type": "FDA Approval",
        "date": "2025-01-24",
        "title": "FRINDOVYX - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210852",
        "source": "openFDA API"
    },
    {
        "company": "Ionis Pharma",
        "drug": "ACETAZOLAMIDE",
        "type": "FDA Approval",
        "date": "2025-01-27",
        "title": "ACETAZOLAMIDE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A217197",
        "source": "openFDA API"
    },
    {
        "company": "Bioage Labs",
        "drug": "OXCARBAZEPINE",
        "type": "FDA Approval",
        "date": "2025-02-07",
        "title": "OXCARBAZEPINE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A216749",
        "source": "openFDA API"
    },
    {
        "company": "Bioage Labs",
        "drug": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE",
        "type": "FDA Approval",
        "date": "2025-02-21",
        "title": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A205299",
        "source": "openFDA API"
    },
    {
        "company": "Harrow Health",
        "drug": "DEXLANSOPRAZOLE",
        "type": "FDA Approval",
        "date": "2025-08-14",
        "title": "DEXLANSOPRAZOLE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A202294",
        "source": "openFDA API"
    },
    {
        "company": "Ionis Pharma",
        "drug": "DYANAVEL XR 20",
        "type": "FDA Approval",
        "date": "2025-09-23",
        "title": "DYANAVEL XR 20 - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210526",
        "source": "openFDA API"
    },
    {
        "company": "Agios Pharm",
        "drug": "TICAGRELOR",
        "type": "FDA Approval",
        "date": "2025-10-28",
        "title": "TICAGRELOR - ORIG Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A212258",
        "source": "openFDA API"
    },
    {
        "company": "Agios Pharm",
        "drug": "ATORVASTATIN CALCIUM",
        "type": "FDA Approval",
        "date": "2025-11-13",
        "title": "ATORVASTATIN CALCIUM - ORIG Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A220276",
        "source": "openFDA API"
    },
    {
        "company": "Black Diamond",
        "drug": "Check Source",
        "type": "Press Release",
        "date": "2025-12-02",
        "title": "BLACK PEARL Partners with Getty Images and Canon to Launch Latest \u2018Culture@\u2019 Campaign",
        "link": "https://www.globenewswire.com/news-release/2025/12/02/3198071/0/en/BLACK-PEARL-Partners-with-Getty-Images-and-Canon-to-Launch-Latest-Culture-Campaign.html",
        "source": "GlobeNewswire Healthcare"
    },
    {
        "company": "Arcturus Therapeutics Holdings Inc",
        "drug": "Check Source",
        "type": "Press Release",
        "date": "2025-12-17",
        "title": "WeShop Expands Retail Partnerships with Top Brands, Bringing More Choices to Shoppers",
        "link": "https://www.globenewswire.com/news-release/2025/12/17/3206988/0/en/WeShop-Expands-Retail-Partnerships-with-Top-Brands-Bringing-More-Choices-to-Shoppers.html",
        "source": "GlobeNewswire Healthcare"
    },
    {
        "company": "Ionis Pharma",
        "drug": "FENTANYL CITRATE",
        "type": "FDA Approval",
        "date": "2025-12-22",
        "title": "FENTANYL CITRATE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215870",
        "source": "openFDA API"
    },
    {
        "company": "Agios Pharm",
        "drug": "PROMETHAZINE WITH CODEINE",
        "type": "FDA Approval",
        "date": "2025-12-22",
        "title": "PROMETHAZINE WITH CODEINE - SUPPL Approved",
        "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=A040650",
        "source": "openFDA API"
    },
    {
        "company": "Twist Bioscience",
        "drug": "Check Source",
        "type": "Press Release",
        "date": "2026-01-30",
        "title": "Cate & Chloe Highlights Valentine\u2019s Day Hoop Earrings Available at Walmart",
        "link": "https://www.globenewswire.com/news-release/2026/01/30/3229639/0/en/Cate-Chloe-Highlights-Valentine-s-Day-Hoop-Earrings-Available-at-Walmart.html",
        "source": "GlobeNewswire Healthcare"
    },
    {
        "company": "SIGA Tech",
        "drug": "Check Source",
        "type": "Press Release",
        "date": "2026-02-09",
        "title": "Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan",
        "link": "https://www.prnewswire.com/news-releases/baird-medical-accelerates-global-commercial-roadmap-with-strategic-clinical-education-initiatives-in-the-us-and-japan-302682296.html",
        "source": "PRNewsWire"
    },
    {
        "company": "Ionis Pharma",
        "drug": "Check Source",
        "type": "Press Release",
        "date": "2026-02-09",
        "title": "SQ Innovation's Lasix\u00ae ONYU Now Available for Order Through Major U.S. Pharmaceutical Distributors",
        "link": "https://www.prnewswire.com/news-releases/sq-innovations-lasix-onyu-now-available-for-order-through-major-us-pharmaceutical-distributors-302682200.html",
        "source": "PRNewsWire"
    },
    {
        "company": "Merck & Co., Inc.",
        "drug": "KEYTRUDA (pembrolizumab)",
        "type": "PDUFA Date",
        "date": "2026-02-20",
        "title": "FDA Decision Expected: KEYTRUDA + chemotherapy for Ovarian Cancer",
        "link": "https://www.merck.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Vanda Pharmaceuticals Inc.",
        "drug": "Bysanti (milsaperidone)",
        "type": "PDUFA Date",
        "date": "2026-02-21",
        "title": "FDA Decision Expected: Bysanti for Bipolar/Schizophrenia",
        "link": "https://www.vandapharma.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Eton Pharmaceuticals, Inc.",
        "drug": "ET-600 (Desmopressin Oral Solution)",
        "type": "PDUFA Date",
        "date": "2026-02-25",
        "title": "FDA Decision Expected: ET-600 for Diabetes Insipidus",
        "link": "https://www.etonpharma.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Ascendis Pharma A/S",
        "drug": "TransCon CNP (navepegritide)",
        "type": "PDUFA Date",
        "date": "2026-02-28",
        "title": "FDA Decision Expected: TransCon CNP for Achondroplasia",
        "link": "https://www.ascendispharma.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "BioMarin Pharmaceutical Inc.",
        "drug": "PALYNZIQ (pegvaliase-pqpz)",
        "type": "PDUFA Date",
        "date": "2026-02-28",
        "title": "FDA Decision Expected: PALYNZIQ for PKU in Adolescents",
        "link": "https://www.biomarin.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Sanofi/Regeneron",
        "drug": "Dupixent (dupilumab)",
        "type": "PDUFA Date",
        "date": "2026-02-28",
        "title": "FDA Decision Expected: Dupixent for AFRS",
        "link": "https://www.dupixent.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Aquestive Therapeutics",
        "drug": "Anaphylm (epinephrine sublingual film)",
        "type": "PDUFA Date",
        "date": "2026-03-15",
        "title": "FDA Decision Expected: Anaphylm for Anaphylaxis",
        "link": "https://www.aquestive.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "MannKind Corporation",
        "drug": "Afrezza (inhalable insulin)",
        "type": "PDUFA Date",
        "date": "2026-03-31",
        "title": "FDA Decision Expected: Afrezza Label Expansion",
        "link": "https://www.mannkindcorp.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Arvinas, Inc.",
        "drug": "Vepdegestrant (ARV-471)",
        "type": "PDUFA Date",
        "date": "2026-04-30",
        "title": "FDA Decision Expected: Vepdegestrant for Breast Cancer",
        "link": "https://www.arvinas.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Pfizer Inc.",
        "drug": "Atirmociclib",
        "type": "PDUFA Date",
        "date": "2026-04-30",
        "title": "FDA Decision Expected: Atirmociclib for Breast Cancer",
        "link": "https://www.pfizer.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Biogen Inc./Eisai Co.",
        "drug": "LEQEMBI (lecanemab)",
        "type": "PDUFA Date",
        "date": "2026-05-24",
        "title": "FDA Decision Expected: LEQEMBI Initiation Treatment for Alzheimer's",
        "link": "https://www.biogen.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "AstraZeneca PLC",
        "drug": "Camizestrant",
        "type": "PDUFA Date",
        "date": "2026-06-30",
        "title": "FDA Decision Expected: Camizestrant for Breast Cancer",
        "link": "https://www.astrazeneca.com/",
        "source": "PDUFA Calendar"
    },
    {
        "company": "Cyngn",
        "drug": "Phase 3 Gene Therapy Candidate",
        "type": "PDUFA Date",
        "date": "2026-06-30",
        "title": "FDA Decision Expected",
        "link": "https://www.cyngn.com/",
        "source": "PDUFA Calendar"
    }
]